TYME—Caveat emptor re data in pancreatic cancer: https://globenewswire.com/news-release/2018/01/19/1297899/0/en/Tyme-Announces-Positive-Efficacy-Data-for-SM-88-in-Pancreatic-Cancer-at-2018-ASCO-Gastrointestinal-Cancers-Symposium.html I have a hard time believing these data are entirely kosher.